Studies on ACTA2 mutations have demonstrated that mutationcarriers show various vasculopathies, including premature onset of coronary arterydisease (CAD), premature ischemic strokes (including Moyamoya disease), and familialthoracic aortic aneurysms and dissections (TAADs)[2]. This evidence concerns the gene ACTA2 and Moyamoya disease.